Member access

4-Traders Homepage  >  Shares  >  Oslo Bors  >  Photocure ASA    PHO   NO0010000045

PHOTOCURE ASA (PHO)

4
 SummaryChart AnalysisNewsCalendarCompanyFinancialsConsensus 
Quotes 5-day view   End-of-day quote. End-of-day quote Oslo Bors
01/19/2015 01/20/2015 01/21/2015 01/22/2015 01/23/2015 Date
35.1 35.2 36.7 36.5 37 Last
10720 5780 35913 16450 31116 Volume
+3.24% +0.28% +4.26% -0.54% +1.37% Change
Company
Photocure ASA develops and markets pharmaceuticals and medical devices based on proprietary photodynamic technology.It operates through the Cancer and Dermatology segments.The Cancer segment consists of the sale from Hexvix to pharmaceutical wholesalers in Nordic markets and Cysview in the United... 
Sector
Pharmaceuticals
Calendar
02/12Earnings Release
More about the company
Chart PHOTOCURE ASA
Duration : Period :
Photocure ASA Technical Analysis Chart | PHO | NO0010000045 | 4-Traders
Full-screen chart
Latest news on PHOTOCURE ASA
01/13 PHOTOCURE ASA : Announces end of phase 2 status achieved for cevira in u.s.
2014 PHOTOCURE ASA : Exercise of employee share options
2014 PHOTOCURE ASA : Exercise of employee share options
2014 PHOTOCURE ASA : 2014 business performance goals update
2014 PHOTOCURE ASA : Focus on Cevira®: Review article published in Expert Opinion of ..
2014 PHOTOCURE ASA : Implementing Hexaminolevulinate HCl Blue Light Cystoscopy: A Nur..
2014 PHOTOCURE ASA : Results for third quarter and the first nine months 2014
2014 PHOTOCURE ASA : Cevira® featured in the Nolato Magazine
More news
Sector news Pharmaceuticals - NEC
11:54a JOHNSON & JOHNSON : New Powered Vascular Stapler From Ethicon Offers Greater Pre..
11:00a MYLAN : Expands Hepatitis C Licensing Agreement with Gilead to Include Investiga..
09:45a GLAXOSMITHKLINE : Glaxo Expands Portfolio Of Medicines In US To Treat Asthma And..
Plus d'actualités du secteur Pharmaceuticals - NEC


Comments 
Advertisement
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF